Dr. Petros Grivas discusses the importance of tailoring treatment decisions in bladder cancer based on data from three ...

Writer Josh Burt recounts what happened when his wife, Hannah, was diagnosed with bladder cancer – and how he tried not to ...

New bladder cancer treatment rolled out by NHS - Hundreds will benefit after the first targeted treatment for the most common ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration ...

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

Erdafitinib, also known as Balversa and made by Johnson & Johnson, is recommended in final draft guidance for adults with metastatic or unresectable FGFR-altered urothelial cancer who have previously ...

A supplemental biologics license application has been submitted to the FDA for nogapendekin alfa plus Bacillus ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

A new systematic review explores how prehabilitation—through exercise, education, nutrition, and lifestyle changes—affects ...

The first targeted treatment for the most common form of bladder cancer has been given the green light for NHS use ...